← Open Payments lookup

MARK MATTA: Open Payments

NPI 1245424084 · NEW CASTLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$258,179 in 464 payments from 18 companies in 2025. Trend: 2023 $140,534 · 2024 $184,844 · 2025 $258,179

Speaker / faculty: $188,007Travel & lodging: $47,384Consulting: $12,386Food & beverage: $10,301Education: $101
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)67$70,799
Vanda Pharmaceuticals Inc.101$70,600
E.R. Squibb & Sons, L.L.C.48$34,544
Teva Pharmaceuticals USA, Inc.48$28,008
Otsuka America Pharmaceutical, Inc.47$26,363
Alkermes, Inc.53$21,235
ABBVIE INC.42$5,312
Neurocrine BioSciences, Inc.13$470
Janssen Pharmaceuticals, Inc12$227
Corium, LLC7$114

Products named: CAPLYTA, FANAPT, COBENFY, REXULTI, LYBALVI, AUSTEDO XR, UZEDY, VRAYLAR.

Industry payments across PA — which companies pay providers there.